Amryt Pharmaceuticals DAC drugs
3 results
Filsuvez (birch triterpenes)
(birch triterpenes)Amryt Pharmaceuticals DAC
Usage: FILSUVEZ is indicated for treating wounds related to dystrophic and junctional epidermolysis bullosa (EB) in adults and pediatric patients aged 6 months and older.
Juxtapid (lomitapide mesylate)
(lomitapide mesylate)Amryt Pharmaceuticals DAC
Usage: JUXTAPID is indicated as an adjunct to a low-fat diet and other lipid-lowering treatments for reducing LDL cholesterol and related measures in patients with homozygous familial hypercholesterolemia (HoFH). Its safety and efficacy in other forms of hypercholesterolemia are not established.
Myalept (metreleptin)
(metreleptin)Amryt Pharmaceuticals DAC
Usage: MYALEPT (metreleptin) is indicated as an adjunct to diet for treating complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy. Its safety and effectiveness are not established for partial lipodystrophy, liver disease, or HIV-related lipodystrophy.